BLX-028914

· Dart NeuroScience, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLX-028914, covering 2013-03-13 to 2013-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis [Phase 2]